Clinical Report: Evaluation of Testicular Cancer Screening in Adolescents
Overview
A nationwide retrospective cohort study of 300,793 Israeli males aged 16 to 21 years assessed the effectiveness of clinical testicular cancer screening before mandatory military service. The study found a low incidence of testicular cancer, limited screening sensitivity, and a high number needed to screen, indicating routine screening in asymptomatic adolescents is ineffective.
Background
Testicular cancer is the most common malignancy in males aged 15 to 34 years, with increasing incidence over recent decades. Screening methods include physician examination and self-examination, but their accuracy and cost-effectiveness remain unclear. The US Preventive Services Task Force recommends against routine screening due to the disease's rarity and favorable treatment outcomes, though data on screening accuracy and number needed to screen have been limited. This study aimed to evaluate these parameters in a large, population-based cohort.
Data Highlights
Parameter
Value
Study population
300,793 males aged 16-21 years
Follow-up duration
1,172,603 person-years
Testicular cancer cases identified
43
Incidence rate
3.67 per 100,000 person-years
Sensitivity of screening at 6 months
66.7%
Sensitivity of screening at 12 months
40%
Number needed to screen to detect one cancer
75,198 adolescents
Ultrasound tests per cancer detected
176
Specialist consultations per cancer detected
112
Stage at diagnosis
Mostly stage I regardless of screening
Key Findings
Testicular cancer incidence was low at 3.67 per 100,000 person-years among screened adolescents.
Screening sensitivity was moderate at 66.7% within 6 months but dropped to 40% at 12 months post-screening.
The number needed to screen to detect one case was very high at 75,198 adolescents.
Screening led to frequent additional evaluations, including 176 ultrasounds and 112 specialist consultations per cancer detected.
Most cancers were diagnosed at stage I, regardless of whether screening was performed.
Overall, routine clinical screening showed low effectiveness and poor cost-efficiency in this population.
Clinical Implications
Routine testicular cancer screening by clinical examination in asymptomatic adolescent males is not supported due to low sensitivity, high number needed to screen, and frequent unnecessary follow-up procedures. Clinicians should focus on educating adolescents about testicular self-awareness and prompt evaluation of symptoms rather than routine screening. Resources may be better allocated to symptomatic individuals or higher-risk populations.
Conclusion
This large population-based study demonstrates that routine clinical screening for testicular cancer in asymptomatic adolescents is ineffective and inefficient. These findings support current recommendations against routine screening in this age group.
References
US Preventive Services Task Force 2011 -- Screening for Testicular Cancer
Israel Defense Forces Medical Corps -- Nationwide Testicular Cancer Screening Study 2012-2021
